Company intelligence / Profile preview

Ventis Pharma

Newport Beach, California, United States

Ownership: Private
Employees: ~20
Development stage: Other

Overview

Ventis Pharma has patented and commercialized Endura-KT/Enduracaine, an opioid-free, local anesthetic product for post-operative and chronic pain. Early clinical and market use data emphasize safety (low toxicity), efficacy, versatility for both adults and children, and significant potential for opioid-sparing post-surgical pain management. The company has partnerships for US distribution and has licensing for FDA 503B manufacturing, but there is no public reporting of Phase 3 or NDA-style trials as would be customary for a new chemical entity since this is a novel combination of approved substances[1][3][6].

Therapeutic areas: Neurology
Modalities: Small moleculeCombination drug
Industry: Biotech

Drug pipeline

1 asset

Endura-KT

Unknown

Partnerships

InfuSystem Holdings (US national sales and marketing agreement)[3][5]Cessatech (co-development and commercialization for CT001 in the US)[2]Nubratori RX (licensed manufacturing partner, FDA 503B Outsourcing Facility)[6]

Beyond the preview

Go deeper on Ventis Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ventis Pharma.

Explore the full profile